CS logo
small CS logo
Gyeongsang National University Hospital

Jinju, Korea, Republic of
University hospital in Jinju
79 Gangnam-ro, Jinju-si, Gyeongsangnam-do

About Gyeongsang National University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Seoul National University Hospital
10
Seung-Jung Park
7
Gyeongsang National University Hospital
5
Boehringer Ingelheim
4
Hoffmann-La Roche
4
Janssen Research & Development, LLC
3
Pusan National University Hospital
3
Asan Medical Center
2
Australasian Gastro-Intestinal Trials Group
2
Celgene
2
Gilead Sciences
2
Total Rows: 38

Clinical Trials at Gyeongsang National University Hospital


During the past decade, Gyeongsang National University Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 6 clinical trials were completed, i.e. on average, 14% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years668855009977552211221100111100110000Started TrialsCompleted Trails2015201620172018201920202021202220230510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
2006-06-01
2013-10-01
Completed
372
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
2006-05-31
2008-12-31
Completed
199
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
2008-03-13
2012-12-28
Completed
95
Optimal Stenting Strategy For True Bifurcation Lesions
2008-01-01
2015-06-01
Completed
420
Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch
2008-01-01
2015-01-01
Completed
504
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2009-01-01
2014-07-01
Completed
91
Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea
2009-03-01
2010-03-01
Completed
509
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
2009-05-01
2009-11-01
Completed
80

Rows per page:

1–74 of 74

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gyeongsang National University Hospital" #1 sponsor was "Seoul National University Hospital" with 10 trials, followed by "Seung-Jung Park" with 7 trials sponsored, "Gyeongsang National University Hospital" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gyeongsang National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 7 trials as a collaborator, "Gyeongsang National University Hospital" with 4 trials as a collaborator, "Seoul National University Bundang Hospital" with 4 trials as a collaborator, "Asan Medical Center" with 3 trials as a collaborator and "Chonbuk National University Hospital" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 61 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSeoul NationalUniversity Hospital: 10Seoul NationalUniversity Hospital: 10Seung-Jung Park: 7Seung-Jung Park: 7Gyeongsang NationalUniversity Hospital: 5Gyeongsang NationalUniversity Hospital: 5Boehringer Ingelheim: 4Boehringer Ingelheim: 4Hoffmann-La Roche: 4Hoffmann-La Roche: 4Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Pusan NationalUniversity Hospital: 3Pusan NationalUniversity Hospital: 3Asan Medical Center: 2Asan Medical Center: 2Australasian Gastro-Intestinal Trials Group:2Australasian Gastro-Intestinal Trials Group:2Celgene: 2Celgene: 2

Created with Highcharts 11.1.0Top CollaboratorsCardioVascularResearch Foundation,Korea: 7CardioVascularResearch Foundation,Korea: 7Gyeongsang NationalUniversity Hospital: 4Gyeongsang NationalUniversity Hospital: 4Seoul NationalUniversity BundangHospital: 4Seoul NationalUniversity BundangHospital: 4Asan Medical Center: 3Asan Medical Center: 3Chonbuk NationalUniversity Hospital: 3Chonbuk NationalUniversity Hospital: 3Hallym UniversityMedical Center: 3Hallym UniversityMedical Center: 3Abbott: 2Abbott: 2Academic andCommunity CancerResearch United: 2Academic andCommunity CancerResearch United: 2Bayer: 2Bayer: 2Chonnam NationalUniversity Hospital: 2Chonnam NationalUniversity Hospital: 2

Clinical Trials Conditions at Gyeongsang National University Hospital


According to Clinical.Site data, the most researched conditions in "Gyeongsang National University Hospital" are "Coronary Artery Disease" (12 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Breast Cancer" (3 trials), "Solid Tumor" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Gyeongsang National University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Gyeongsang National University Hospital


Most popular intervention types in "Gyeongsang National University Hospital" are "Drug" (47 trials), "Device" (9 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (7 trials), "Placebo" (5 trials), "Paclitaxel" (4 trials), "Pemetrexed" (4 trials) and "Cypher" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Gyeongsang National University Hospital


The vast majority of trials in "Gyeongsang National University Hospital" are 72 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Gyeongsang National University Hospital


Currently, there are NaN active trials in "Gyeongsang National University Hospital". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Gyeongsang National University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gyeongsang National University Hospital, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 19Phase 3: 19Phase 4: 14Phase 4: 14Phase 2: 8Phase 2: 8Not Applicable: 5Not Applicable: 5Phase 1: 4Phase 1: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 36Completed: 36Recruiting: 15Recruiting: 15Active, not recruiting: 11Active, not recruiting: 11Unknown status: 10Unknown status: 10Approved for marketing: 1Approved for marketing: 1Terminated: 1Terminated: 1